CVE-2026-54051Network-AI has an an OS Command Injection issue
Updated under an hour ago ()
Does this affect you?
It affects Jovancoding Network-AI. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
Network-AI is a TypeScript/Node.js multi-agent orchestrator. Prior to version 5.9.1, the agent sandbox gates shell commands behind an allowlist (`SandboxPolicy.isCommandAllowed`), which THREAT_MODEL.md calls the main control against a compromised agent (Adversary 3.2). The allowlist glob-matches the whole command string, but `ShellExecutor` runs that string through `/bin/sh -c`. So any wildcard allow such as `git *`, `npm *` or `node *` also matches `git status; <anything>`, and a scoped command becomes arbitrary execution. The issue is fixed in v5.9.1. `ShellExecutor` now executes via `spawn(file, args, { shell: false })` using a quote-aware parsed argv, so no shell is invoked. `SandboxPolicy.isCommandAllowed` and the new `SandboxPolicy.tokenizeCommand` reject any unquoted shell metacharacter (`; & | $ ` ` ` ( ) < > { }` newline) or unterminated quote before the allowlist glob match; quoted metacharacters are preserved as literal argument data. Users should upgrade to `network-ai@5.9.1` or later. As defense in depth, avoid broad wildcard allowlist entries such as `node *` / `npm *` which are direct code execution by design.
- CVSS
- 9.9 CRITICAL (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
- Weakness (CWE)
- CWE-78
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- GitHub_M
- NVD analysis
- Deferred
- Record last updated
- Jul 21, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.